Study of QL2302 vs Tezspire for severe asthma
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new medicine, QL2302, to see how well it works compared to an approved treatment called Tezspire for people with severe asthma. If you have asthma that is not well controlled despite using daily inhalers and other medications, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You weigh at least 40 kg (about 88 pounds)
- You have had asthma for at least 1 year
- You use a medium or high dose of inhaled steroids every day for at least 3 months, plus at least one other asthma controller medicine
- Your lung function test shows that your breathing is below normal but not extremely low
- You have had at least 1 asthma flare-up that needed treatment in the last year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
This trial tests a drug called tezepelumab to see if it helps control severe asthma in adults. It may be an option if your asthma is hard to manage with current treatments and you have frequent symptoms or flare-ups.
This trial tests an investigational drug called TQC2731 for people with severe asthma that is not well controlled despite high-dose inhaled steroids. The study aims to see if this treatment can reduce asthma attacks.
This trial tests a new biologic drug (tezepelumab) to see if it improves symptoms in people with both chronic sinusitis with nasal polyps and severe asthma. The goal is to reduce inflammation and help you breathe better. Participants must not have had prior sinus surgery.
This study tests a new medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It is for adults who have had asthma for at least a year, have had recent flare-ups needing steroids, and are not taking other biologic treatments.
This trial tests a new inhaled medication called LQ036 to see if it can help people whose asthma is not well controlled with their current inhalers. Participants must have had at least one severe asthma flare-up in the last year and show signs of airway inflammation.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.